Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: Phase I studies (vol 24, pg 81, 1997)

被引:0
|
作者
Rosenthal
Carbone, DP
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:499 / 499
页数:1
相关论文
共 14 条
  • [1] Intensive radiation therapy concurrent with up to 7-week continuous-infusion paclitaxel for locally advanced solid tumors: Phase I studies
    Rosenthal, DI
    Okani, O
    Truelson, JM
    FathallahShaykh, H
    Vuitch, FM
    Gazdar, AF
    Griener, J
    Landay, M
    Mendelsohn, D
    Tourville, J
    Hamilton, L
    Orr, KY
    McWhorter, J
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S81 - S84
  • [2] Concurrent intensive radiotherapy and prolonged continuous-infusion paclitaxel for locally advanced solid tumors: Results of three phase I trials
    Rosenthal, DI
    Okani, O
    Sinard, RJ
    Truelson, JM
    Fink, KL
    Kamen, B
    Vuitch, FM
    Griener, J
    Orr, KY
    McWhorter, J
    Carbone, DP
    SEMINARS IN RADIATION ONCOLOGY, 1997, 7 (02) : S42 - S46
  • [3] PHASE-I STUDIES OF CONTINUOUS-INFUSION PACLITAXEL GIVEN WITH STANDARD AGGRESSIVE RADIATION-THERAPY FOR LOCALLY ADVANCED SOLID TUMORS
    ROSENTHAL, DI
    CLOSE, LG
    LUCCI, JA
    SCHOLD, SC
    TRUELSON, J
    FATHALLAHSKAYKH, H
    KAMEN, B
    VUITCH, FM
    GAZDAR, AF
    GRIENER, J
    LANDAY, M
    MENDELSOHN, D
    TOURVILLE, J
    ROGERS, P
    ORR, KY
    MCWHORTER, J
    CARBONE, DP
    SEMINARS IN ONCOLOGY, 1995, 22 (04) : 13 - 17
  • [4] Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: A phase I study
    Rosenthal, DI
    Okani, O
    Corak, J
    Kavanaugh, D
    Kamen, B
    Vuitch, FM
    Gazdar, AF
    Greiner, J
    Frenkel, EF
    Carbone, DP
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 96 - 100
  • [5] Seven-week continuous-infusion paclitaxel with concurrent radiotherapy for locally advanced head and neck squamous cell cancer: A phase I study
    Rosenthal, DI
    Sinard, RJ
    Okani, O
    Corak, J
    Kavanaugh, D
    Kamen, B
    Vuitch, FM
    Gazdar, AF
    Griener, J
    Frenkel, EP
    Carbone, DP
    SEMINARS IN ONCOLOGY, 1997, 24 (06) : S67 - S71
  • [6] Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers
    Dowell, JE
    Sinard, R
    Yardley, DA
    Aviles, V
    Machtay, M
    Weber, RS
    Weinstein, GS
    Chalian, AA
    Carbone, DP
    Rosenthal, DI
    SEMINARS IN RADIATION ONCOLOGY, 1999, 9 (02) : 97 - 101
  • [7] Continuous-infusion paclitaxel and weekly cisplatin with concurrent radiation therapy for locally advanced non-small cell lung cancer
    Cho, E
    Jeong, S
    Ahn, C
    Lee, S
    Park, J
    Kyung, S
    Lee, K
    Park, S
    Bang, S
    Shin, D
    LUNG CANCER, 2005, 49 : S241 - S241
  • [8] Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck
    Rosenthal, DI
    Lee, JH
    Sinard, R
    Yardley, DA
    Machtay, M
    Rosen, DM
    Egorin, MJ
    Weber, RS
    Weinstein, GS
    Chalian, AA
    Miller, LK
    Frenkel, EP
    Carbone, DP
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1363 - 1373
  • [9] Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancer
    Rosenthal, David I.
    Fuller, Clifton David
    Machtay, Mitchell
    Algazy, Kenneth M.
    Meyer, Dan M.
    Kaiser, Larry R.
    Yardley, Denise A.
    Loiacano, Megan E.
    Carbone, David P.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (01) : 38 - 45
  • [10] Two phase I studies of concurrent radiation therapy with continuous-infusion 5-fluorouracil plus epirubicin, and either cisplatin or irinotecan for locally advanced upper gastrointestinal adenocarcinomas
    Weijing Sun
    James M. Metz
    Maryann Gallagher
    Peter J. O’Dwyer
    Bruce Giantonio
    Richard Whittington
    Daniel G. Haller
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 621 - 627